SIL204 treatment may help immune system attack KRAS-driven tumors, research finds - exclusive ByDANYA SAPERSTEIN AUGUST 5, 2026 14:38 Updated: AUGUST 5, 2026 14:47

SIL204 treatment may help immune system attack KRAS-driven tumors, research finds - exclusive This comes just after SIL204 advanced into Phase 2/3 clinical evaluation at the end of July, beginning its first clinical trial at Tel Aviv Sourasky Medical Center. https://www.jpost.com/health-and-wellness/article-904667 ByDANYA SAPERSTEIN AUGUST 5, 2026 14:38 Updated: AUGUST 5, 2026 14:47